OS6.5 ERGO2: A prospective randomized trial of a 9-day schedule of calorically restricted ketogenic diet and fasting or standard diet in addition to re-irradiation for malignant glioma

BACKGROUND: Ketogenic diet (KD) and fasting have anticancer effects in tumor models, possibly due to a differential stress response with sensitization of tumor cells and protection of normal tissue. We therefore set up ERGO2 (NCT01754350), the first randomized clinical trial of calorically-restricte...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Voss, M, Wagner, M, von Mettenheim, N, Harter, P N, Wenger, K, Franz, K, Bojunga, J, Gerlach, R, Glatzel, M, Paulsen, F, Hattingen, E, Baehr, O, Ronellenfitsch, M W, Fokas, E, Imhoff, D, Steinbach, J P, Rödel, C, Rieger, J
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Oral Presentations
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6795119/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz126.043
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars